Literature DB >> 1709275

Mutations in mitochondrial tRNA genes: a frequent cause of neuromuscular diseases.

J Lauber1, C Marsac, B Kadenbach, P Seibel.   

Abstract

We have sequenced the tRNA genes of mtDNA from patients with chronic progressive external ophthalmoplegia (CPEO) without detectable mtDNA deletions. Four point mutations were identified, located within highly conserved regions of mitochondrial tRNA genes, namely tRNA(Leu)(UAG), tRNA(Ser)(GCU), tRNA(Gly) and tRNA(Lys). One of these mutations (tRNA(Leu)(UAG)) was found in four patients with different forms of mitochondrial myopathy. An accumulation of three different tRNA point mutations (tRNA(Leu)(UAG)), tRNA(Ser)(GCU) and tRNA(Gly) was observed in a single patient, suggesting that mitochondrial tRNA genes represent hotspots for point mutations causing neuromuscular diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709275      PMCID: PMC333891          DOI: 10.1093/nar/19.7.1393

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Identification of point mutations by mispairing PCR as exemplified in MERRF disease.

Authors:  P Seibel; F Degoul; N Romero; C Marsac; B Kadenbach
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

2.  Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome.

Authors:  S Shanske; C T Moraes; A Lombes; A F Miranda; E Bonilla; P Lewis; M A Whelan; C A Ellsworth; S DiMauro
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

3.  Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome.

Authors:  A Rotig; M Colonna; J P Bonnefont; S Blanche; A Fischer; J M Saudubray; A Munnich
Journal:  Lancet       Date:  1989-04-22       Impact factor: 79.321

4.  Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease.

Authors:  D C Wallace; X X Zheng; M T Lott; J M Shoffner; J A Hodge; R I Kelley; C M Epstein; L C Hopkins
Journal:  Cell       Date:  1988-11-18       Impact factor: 41.582

5.  Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.

Authors:  D C Wallace; G Singh; M T Lott; J A Hodge; T G Schurr; A M Lezza; L J Elsas; E K Nikoskelainen
Journal:  Science       Date:  1988-12-09       Impact factor: 47.728

6.  Assignment of two mitochondrially synthesized polypeptides to human mitochondrial DNA and their use in the study of intracellular mitochondrial interaction.

Authors:  N A Oliver; D C Wallace
Journal:  Mol Cell Biol       Date:  1982-01       Impact factor: 4.272

7.  Maternal inheritance of deleted mitochondrial DNA in a family with mitochondrial myopathy.

Authors:  T Ozawa; M Yoneda; M Tanaka; K Ohno; W Sato; H Suzuki; M Nishikimi; M Yamamoto; I Nonaka; S Horai
Journal:  Biochem Biophys Res Commun       Date:  1988-08-15       Impact factor: 3.575

8.  Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics.

Authors:  A Lombes; J R Mendell; H Nakase; R J Barohn; E Bonilla; M Zeviani; A J Yates; J Omerza; T L Gales; K Nakahara
Journal:  Ann Neurol       Date:  1989-07       Impact factor: 10.422

9.  Deletions of mitochondrial DNA in Kearns-Sayre syndrome.

Authors:  M Zeviani; C T Moraes; S DiMauro; H Nakase; E Bonilla; E A Schon; L P Rowland
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

10.  Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies.

Authors:  I J Holt; A E Harding; J A Morgan-Hughes
Journal:  Nature       Date:  1988-02-25       Impact factor: 49.962

View more
  24 in total

Review 1.  Molecular biology of neurological diseases.

Authors:  W J Cumming
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

Review 2.  Diseases resulting from mitochondrial DNA point mutations.

Authors:  D C Wallace; M T Lott; J M Shoffner; M D Brown
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Chloroplast heteroplasmicity is stabilized by an amber-suppressor tryptophan tRNA(CUA).

Authors:  W Yu; R J Spreitzer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  The sequence of human mtDNA: the question of errors versus polymorphisms.

Authors:  N Howell; D A McCullough; I Kubacka; S Halvorson; D Mackey
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

5.  Different in situ hybridization patterns of mitochondrial DNA in cytochrome c oxidase-deficient extraocular muscle fibres in the elderly.

Authors:  J Müller-Höcker; P Seibel; K Schneiderbanger; B Kadenbach
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 6.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

7.  Classification of European mtDNAs from an analysis of three European populations.

Authors:  A Torroni; K Huoponen; P Francalacci; M Petrozzi; L Morelli; R Scozzari; D Obinu; M L Savontaus; D C Wallace
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

Review 8.  Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: unraveling the pathogenesis of human mitochondrial DNA instability and the initiation of a genetic classification.

Authors:  Gert Van Goethem; Jean-Jacques Martin; Christine Van Broeckhoven
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

9.  Mutations in mitochondrial tRNA genes: non-linkage with syndromes of Wolfram and chronic progressive external ophthalmoplegia.

Authors:  J M van den Ouweland; G J Bruining; D Lindhout; J M Wit; B F Veldhuyzen; J A Maassen
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

10.  A novel mitochondrial tRNA(Val) T1658C mutation identified in a CPEO family.

Authors:  Naihong Yan; Shuping Cai; Bo Guo; Yi Mou; Jing Zhu; Jun Chen; Ting Zhang; Ronghua Li; Xuyang Liu
Journal:  Mol Vis       Date:  2010-08-25       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.